EARNEST Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-59
Closed -$3.71K – 769
2023
Q3
$3.71K Hold
59
– – ﹤0.01% 875
2023
Q2
$3.33K Hold
59
– – ﹤0.01% 901
2023
Q1
$3.42K Hold
59
– – ﹤0.01% 881
2022
Q4
$4.27K Hold
59
– – ﹤0.01% 828
2022
Q3
$4K Hold
59
– – ﹤0.01% 837
2022
Q2
$4K Sell
59
-200
-77% -$13.2K ﹤0.01% 858
2022
Q1
$18K Hold
259
– – ﹤0.01% 510
2021
Q4
$16K Hold
259
– – ﹤0.01% 559
2021
Q3
$16K Hold
259
– – ﹤0.01% 540
2021
Q2
$16K Hold
259
– – ﹤0.01% 539
2021
Q1
$16K Hold
259
– – ﹤0.01% 515
2020
Q4
$12K Hold
259
– – ﹤0.01% 572
2020
Q3
$10K Sell
259
-188
-42% -$7.14K ﹤0.01% 569
2020
Q2
$16K Hold
447
– – ﹤0.01% 449
2020
Q1
$14K Hold
447
– – ﹤0.01% 446
2019
Q4
$23K Hold
447
– – ﹤0.01% 418
2019
Q3
$21K Hold
447
– – ﹤0.01% 433
2019
Q2
$22K Hold
447
– – ﹤0.01% 427
2019
Q1
$19K Hold
447
– – ﹤0.01% 451
2018
Q4
$18K Hold
447
– – ﹤0.01% 434
2018
Q3
$21K Hold
447
– – ﹤0.01% 425
2018
Q2
$19K Hold
447
– – ﹤0.01% 443
2018
Q1
$21K Hold
447
– – ﹤0.01% 422
2017
Q4
$23K Buy
+447
New +$23.5K ﹤0.01% 394
2017
Q1
– Sell
-502
Closed -$24K – 636
2016
Q4
$24K Buy
+502
New +$23K ﹤0.01% 370

Other funds holding MET

EARNEST Partners's MET Position: Q4 2023 in Review

EARNEST Partners sold out of MetLife (MET) in Q4 2023, closing a stake of 59 shares — an estimated $3.71K sold.

EARNEST Partners first reported a position in MET in Q4 2016 and held it in 25 quarters. The position peaked at $24K in Q4 2016. 1,262 funds tracked by Wall St. Rank hold MET as of Q4 2023.

  • EARNEST Partners reported no remaining MetLife position as of Q4 2023 after selling out during the quarter.
  • EARNEST Partners sold 59 MetLife shares in Q4 2023, an estimated $3.71K.
  • EARNEST Partners first reported a position in MetLife in Q4 2016 and held it in 25 quarters.
  • EARNEST Partners's MetLife position peaked at $24K in Q4 2016.
  • 1,262 funds tracked by Wall St. Rank held MetLife as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.